Nephros, Inc.NEPHNASDAQ
Loading
Book Value/Share Growth Under PressureDecelerating
Percentile Rank67
5Y CAGR-44.2%
Year-over-Year Change
Year-over-year book value per share growth
5Y CAGR
-44.2%/yr
Long-term compound
Percentile
P67
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.96% |
| Q3 2025 | 4.13% |
| Q2 2025 | 3.31% |
| Q1 2025 | 7.65% |
| Q4 2024 | 5.03% |
| Q3 2024 | 2.79% |
| Q2 2024 | -3.18% |
| Q1 2024 | -1.74% |
| Q4 2023 | -3.82% |
| Q3 2023 | -1.94% |
| Q2 2023 | -2.69% |
| Q1 2023 | 0.15% |
| Q4 2022 | -7.25% |
| Q3 2022 | -23.27% |
| Q2 2022 | -7.64% |
| Q1 2022 | -10.64% |
| Q4 2021 | -3.79% |
| Q3 2021 | 1.23% |
| Q2 2021 | -4.10% |
| Q1 2021 | -8.74% |
| Q4 2020 | 36.13% |
| Q3 2020 | -7.36% |
| Q2 2020 | -13.94% |
| Q1 2020 | 77.34% |
| Q4 2019 | 2.57% |
| Q3 2019 | -5.27% |
| Q2 2019 | 17.20% |
| Q1 2019 | -17.56% |
| Q4 2018 | 67.15% |
| Q3 2018 | -10.87% |
| Q2 2018 | 108.19% |
| Q1 2018 | -4.85% |
| Q4 2017 | 633.42% |
| Q3 2017 | -66.48% |
| Q2 2017 | -47.29% |
| Q1 2017 | 102.78% |
| Q4 2016 | -45.24% |
| Q3 2016 | -27.61% |
| Q2 2016 | -16.70% |
| Q1 2016 | -25.19% |